Drawing for -ELOSTERA

USPTO serial 79300352

-ELOSTERA

Reviewed by CopyMark Law Group

Reg. 6488730Status 700Renewal
Filing date
Status date
Registration date
Sep 21, 2021
Examiner
WHITE, TRAVIS WILLIAM
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with -ELOSTERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; chemicals for use in biotechnological manufacturing processes; antioxidants for use in the manufacture of pharmaceuticalsACTIVE
005Pharmaceutical preparations for preventing spread of cancer cells; pharmaceutical preparations for mitigating negative side effects of chemo- and radiotherapy related to cancer; pharmaceutical preparations for controlling diabetes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for treating malignant tumors; veterinary preparations, namely, preparations for preventing spread of cancer cells and mitigating negative side effects of chemo- and radiotherapy related to cancer; medical preparations for the reduction of side effects of chemotherapy and radiation therapy; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical compositions for the treatment and prevention of cancer; empty capsules for pharmaceuticals; nutritional supplements for veterinary use; dietary supplements for human beings and animalsACTIVE
031Raw and unprocessed agricultural, aquacultural, horticultural and forestry products, namely, plant seeds, sowing seeds, crop seeds, unprocessed oil seeds, seeds for fruit and vegetables, seeds for planting, seeds for agricultural purposes, bitter melon seeds, genetically modified forms of all the aforementioned seedsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 10, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 22, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 22, 2022FIMPFINAL DISPOSITION PROCESSED
Dec 21, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 21, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 16, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2021RFNTREFUSAL PROCESSED BY IB
Feb 9, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 9, 2021RFRRREFUSAL PROCESSED BY MPU
Jan 28, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 27, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2021DOCKASSIGNED TO EXAMINER
Jan 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Dec 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance